Iran Faces Critical Shortage of Medicines Amid US Sanctions

TEHRAN: Iran is grappling with a severe shortage of medicines, a situation exacerbated by ongoing US sanctions. Many essential drugs are now unavailable, while those that can be found are priced exorbitantly, raising concerns about public health.

According to reports from international news agencies, Iran produces approximately 80% of its medicines domestically. However, a significant portion of these pharmaceuticals relies on imported raw materials, which have become increasingly difficult to obtain due to sanctions. Health officials have warned that the situation could worsen if immediate measures are not taken to address the supply chain disruptions.

This shortage poses serious implications for the Iranian population, particularly for those with chronic illnesses who depend on regular medication. The rising costs and unavailability of essential drugs could lead to increased health risks and a potential public health crisis, further straining an already struggling healthcare system.

In response to the crisis, Iranian authorities are reportedly exploring options to boost domestic production and negotiate with international suppliers to secure necessary imports. Upcoming meetings among health officials and pharmaceutical representatives are expected to address these urgent issues and seek solutions to alleviate the crisis.